THERAPEUTIC CATALYST

This scheme accelerates the translation of laboratory discoveries into novel cancer therapeutics. It supports exploratory drug discovery focused on validating and de- risking targets, with the long-term goal of developing novel anti-tumoral single-agent therapeutics.